247 related articles for article (PubMed ID: 23060470)
1. Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
Singh B; Sharma B; Jaggi AS; Singh N
J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):124-36. PubMed ID: 23060470
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimer's type.
Sodhi RK; Singh N
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():38-46. PubMed ID: 23044340
[TBL] [Abstract][Full Text] [Related]
3. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.
Sharma B; Singh N; Singh M
J Psychopharmacol; 2008 Mar; 22(2):162-71. PubMed ID: 18208924
[TBL] [Abstract][Full Text] [Related]
4. Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia.
Kaur B; Singh N; Jaggi AS
Fundam Clin Pharmacol; 2009 Oct; 23(5):557-66. PubMed ID: 19656209
[TBL] [Abstract][Full Text] [Related]
5. Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation.
Tsukuda K; Mogi M; Iwanami J; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
Hypertension; 2009 Oct; 54(4):782-7. PubMed ID: 19635982
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease.
Jayant S; Sharma BM; Sharma B
Brain Res; 2016 Jul; 1642():397-408. PubMed ID: 27084583
[TBL] [Abstract][Full Text] [Related]
7. Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia.
Sharma B; Singh N; Singh M; Jaggi AS
Pharmacol Biochem Behav; 2008 Jun; 89(4):535-45. PubMed ID: 18343489
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type.
Kumar A; Singh N
Biomed Pharmacother; 2017 Apr; 88():698-707. PubMed ID: 28152479
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease.
Jayant S; Sharma BM; Bansal R; Sharma B
Pharmacol Biochem Behav; 2016 Jan; 140():39-50. PubMed ID: 26577751
[TBL] [Abstract][Full Text] [Related]
10. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
[TBL] [Abstract][Full Text] [Related]
11. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type.
Gutierres JM; Carvalho FB; Schetinger MR; Marisco P; Agostinho P; Rodrigues M; Rubin MA; Schmatz R; da Silva CR; de P Cognato G; Farias JG; Signor C; Morsch VM; Mazzanti CM; Bogo M; Bonan CD; Spanevello R
Life Sci; 2014 Feb; 96(1-2):7-17. PubMed ID: 24291256
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative effects of telmisartan on the inflammatory response and impaired spatial memory in a rat model of Alzheimer's disease incorporating additional cerebrovascular disease factors.
Shindo T; Takasaki K; Uchida K; Onimura R; Kubota K; Uchida N; Irie K; Katsurabayashi S; Mishima K; Nishimura R; Fujiwara M; Iwasaki K
Biol Pharm Bull; 2012; 35(12):2141-7. PubMed ID: 23207766
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin Inhibition and Protein Kinase A Activation Limits Cognitive Dysfunction and Histopathological Damage in a Model of Dementia of the Alzheimer's Type.
Kumar A; Singh N
Curr Neurovasc Res; 2018; 15(3):234-245. PubMed ID: 30101704
[TBL] [Abstract][Full Text] [Related]
14. Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity.
Pinton S; da Rocha JT; Zeni G; Nogueira CW
Neurosci Lett; 2010 Mar; 472(1):56-60. PubMed ID: 20122991
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activation of protein kinase A improves memory loss and neuropathological changes in a mouse model of dementia of Alzheimer's type.
Kumar A; Singh N
Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):187-198. PubMed ID: 28177982
[TBL] [Abstract][Full Text] [Related]
16. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.
Saxena G; Singh SP; Agrawal R; Nath C
Eur J Pharmacol; 2008 Mar; 581(3):283-9. PubMed ID: 18234183
[TBL] [Abstract][Full Text] [Related]
17. Attenuating effect of standardized lyophilized Cinnamomum zeylanicum bark extract against streptozotocin-induced experimental dementia of Alzheimer's type.
Malik J; Munjal K; Deshmukh R
J Basic Clin Physiol Pharmacol; 2015 May; 26(3):275-85. PubMed ID: 25301673
[TBL] [Abstract][Full Text] [Related]
18. Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet.
Sodhi RK; Singh N
PLoS One; 2013; 8(7):e70487. PubMed ID: 23936214
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia.
Kumar A; Singh N
Pharmacol Biochem Behav; 2017 Feb; 153():147-159. PubMed ID: 28063945
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia.
Kasahara Y; Taguchi A; Uno H; Nakano A; Nakagomi T; Hirose H; Stern DM; Matsuyama T
Brain Res; 2010 Jun; 1340():70-80. PubMed ID: 20388500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
